• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾脏疾病中的脂肪酸β-氧化:病理生理机制与治疗机会的展望

Fatty Acid β-Oxidation in Kidney Diseases: Perspectives on Pathophysiological Mechanisms and Therapeutic Opportunities.

作者信息

Gao Zhumei, Chen Xiangmei

机构信息

Department of Nephrology, The Second Hospital of Jilin University, Jilin, China.

Department of Nephrology, The First Medical Center, Chinese PLA General Hospital, Beijing, China.

出版信息

Front Pharmacol. 2022 Apr 20;13:805281. doi: 10.3389/fphar.2022.805281. eCollection 2022.

DOI:10.3389/fphar.2022.805281
PMID:35517820
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9065343/
Abstract

The kidney is a highly metabolic organ and requires a large amount of ATP to maintain its filtration-reabsorption function, and mitochondrial fatty acid β-oxidation serves as the main source of energy to meet its functional needs. Reduced and inefficient fatty acid β-oxidation is thought to be a major mechanism contributing to kidney diseases, including acute kidney injury, chronic kidney disease and diabetic nephropathy. PPARα, AMPK, sirtuins, HIF-1, and TGF-β/SMAD3 activation have all been shown to play key roles in the regulation of fatty acid β-oxidation in kidney diseases, and restoration of fatty acid β-oxidation by modulation of these molecules can ameliorate the development of such diseases. Here, we disentangle the lipid metabolism regulation properties and potential mechanisms of mesenchymal stem cells and their extracellular vesicles, and emphasize the role of mesenchymal stem cells on lipid metabolism. This review aims to highlight the important role of fatty acid β-oxidation in the progression of kidney diseases, and to explore the fatty acid β-oxidation effects and therapeutic potential of mesenchymal stem cells for kidney diseases.

摘要

肾脏是一个高代谢器官,需要大量三磷酸腺苷(ATP)来维持其滤过-重吸收功能,而线粒体脂肪酸β-氧化是满足其功能需求的主要能量来源。脂肪酸β-氧化减少和效率低下被认为是导致肾脏疾病的主要机制,包括急性肾损伤、慢性肾脏病和糖尿病肾病。过氧化物酶体增殖物激活受体α(PPARα)、腺苷酸活化蛋白激酶(AMPK)、沉默调节蛋白、低氧诱导因子-1(HIF-1)以及转化生长因子-β/ 信号转导和转录激活因子3(TGF-β/SMAD3)的激活均已被证明在肾脏疾病中脂肪酸β-氧化的调节中起关键作用,通过调节这些分子来恢复脂肪酸β-氧化可以改善此类疾病的发展。在此,我们剖析间充质干细胞及其细胞外囊泡的脂质代谢调节特性和潜在机制,并强调间充质干细胞在脂质代谢中的作用。本综述旨在突出脂肪酸β-氧化在肾脏疾病进展中的重要作用,并探索间充质干细胞对肾脏疾病的脂肪酸β-氧化作用及治疗潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d1e/9065343/db852497e2d0/fphar-13-805281-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d1e/9065343/db852497e2d0/fphar-13-805281-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d1e/9065343/db852497e2d0/fphar-13-805281-g001.jpg

相似文献

1
Fatty Acid β-Oxidation in Kidney Diseases: Perspectives on Pathophysiological Mechanisms and Therapeutic Opportunities.肾脏疾病中的脂肪酸β-氧化:病理生理机制与治疗机会的展望
Front Pharmacol. 2022 Apr 20;13:805281. doi: 10.3389/fphar.2022.805281. eCollection 2022.
2
Defective Mitochondrial Fatty Acid Oxidation and Lipotoxicity in Kidney Diseases.肾脏疾病中线粒体脂肪酸氧化缺陷与脂毒性
Front Med (Lausanne). 2020 Mar 12;7:65. doi: 10.3389/fmed.2020.00065. eCollection 2020.
3
Proximal tubule cyclophilin D regulates fatty acid oxidation in cisplatin-induced acute kidney injury.近端小管亲环素 D 调节顺铂诱导的急性肾损伤中的脂肪酸氧化。
Kidney Int. 2020 Feb;97(2):327-339. doi: 10.1016/j.kint.2019.08.019. Epub 2019 Sep 3.
4
Hypoxic mesenchymal stem cell-derived extracellular vesicles ameliorate renal fibrosis after ischemia-reperfusion injure by restoring CPT1A mediated fatty acid oxidation.缺氧间充质干细胞衍生的细胞外囊泡通过恢复 CPT1A 介导的脂肪酸氧化改善缺血再灌注损伤后的肾纤维化。
Stem Cell Res Ther. 2022 May 7;13(1):191. doi: 10.1186/s13287-022-02861-9.
5
Dyslipidemia in Kidney Disorders: Perspectives on Mitochondria Homeostasis and Therapeutic Opportunities.肾脏疾病中的血脂异常:线粒体稳态及治疗机会的视角
Front Physiol. 2020 Sep 3;11:1050. doi: 10.3389/fphys.2020.01050. eCollection 2020.
6
Zishen Qingre Tongluo Formula Improves Renal Fatty Acid Oxidation and Alleviated Fibrosis via the Regulation of the TGF-1/Smad3 Signaling Pathway in Hyperuricemic Nephrology Rats.滋肾清热通络方通过调控 TGF-β1/Smad3 信号通路改善高尿酸肾病大鼠肾脏脂肪酸氧化及减轻纤维化。
Biomed Res Int. 2021 Dec 13;2021:2793823. doi: 10.1155/2021/2793823. eCollection 2021.
7
Adiponectin stimulates lipid metabolism via AMPK in rabbit blastocysts.脂联素通过 AMPK 刺激兔囊胚的脂质代谢。
Hum Reprod. 2017 Jul 1;32(7):1382-1392. doi: 10.1093/humrep/dex087.
8
Alteration of Fatty Acid Oxidation in Tubular Epithelial Cells: From Acute Kidney Injury to Renal Fibrogenesis.脂肪酸氧化在肾小管上皮细胞中的改变:从急性肾损伤到肾纤维化。
Front Med (Lausanne). 2015 Aug 5;2:52. doi: 10.3389/fmed.2015.00052. eCollection 2015.
9
PPARα agonist fenofibrate enhances fatty acid β-oxidation and attenuates polycystic kidney and liver disease in mice.过氧化物酶体增殖物激活受体 α 激动剂非诺贝特增强脂肪酸 β 氧化,减轻多囊肾病和肝疾病的小鼠模型的病变。
Am J Physiol Renal Physiol. 2018 Jan 1;314(1):F122-F131. doi: 10.1152/ajprenal.00352.2017. Epub 2017 Sep 13.
10
Cardiac mitochondrial energy metabolism in heart failure: Role of cardiolipin and sirtuins.心力衰竭中的心脏线粒体能量代谢:心磷脂与沉默调节蛋白的作用
Biochim Biophys Acta. 2016 Oct;1861(10):1544-54. doi: 10.1016/j.bbalip.2016.03.008. Epub 2016 Mar 10.

引用本文的文献

1
Identification of Differentially Expressed Genes and Pathways in Non-Diabetic CKD and Diabetic CKD by Integrated Human Transcriptomic Bioinformatics Analysis.通过整合人类转录组生物信息学分析鉴定非糖尿病性慢性肾脏病和糖尿病性慢性肾脏病中差异表达的基因和通路
Int J Mol Sci. 2025 Aug 1;26(15):7421. doi: 10.3390/ijms26157421.
2
Cardiometabolic index is associated with impaired renal function: Nonlinear threshold effects and dose-response relationships in a national cohort (NHANES 1999-2018).心脏代谢指数与肾功能受损相关:一项全国性队列研究(1999 - 2018年美国国家健康与营养检查调查)中的非线性阈值效应和剂量反应关系
Medicine (Baltimore). 2025 Aug 1;104(31):e43653. doi: 10.1097/MD.0000000000043653.
3

本文引用的文献

1
Global Kidney Health Atlas: a spotlight on the Asia-Pacific sector.《全球肾脏健康地图集》:聚焦亚太地区
Kidney Res Clin Pract. 2022 Jan;41(1):22-30. doi: 10.23876/j.krcp.21.236. Epub 2022 Jan 13.
2
Stem cell-derived and circulating exosomal microRNAs as new potential tools for diabetic nephropathy management.干细胞衍生和循环的外泌体 microRNAs 作为糖尿病肾病管理的新潜在工具。
Stem Cell Res Ther. 2022 Jan 24;13(1):25. doi: 10.1186/s13287-021-02696-w.
3
Berberine Reduces Lipid Accumulation by Promoting Fatty Acid Oxidation in Renal Tubular Epithelial Cells of the Diabetic Kidney.
Dimethyl malonate alleviates obstructive nephropathy by enhancing renal metabolism and inhibiting kidney oxidative stress and inflammation.
丙二酸二甲酯通过增强肾脏代谢、抑制肾脏氧化应激和炎症来减轻梗阻性肾病。
Front Pharmacol. 2025 Jun 10;16:1530635. doi: 10.3389/fphar.2025.1530635. eCollection 2025.
4
Associated factors and principal pathophysiological mechanisms of type 2 diabetes mellitus.2型糖尿病的相关因素及主要病理生理机制。
Front Endocrinol (Lausanne). 2025 May 9;16:1499565. doi: 10.3389/fendo.2025.1499565. eCollection 2025.
5
The role of redox signaling in mitochondria and endoplasmic reticulum regulation in kidney diseases.氧化还原信号在线粒体和内质网调控在肾脏疾病中的作用。
Arch Toxicol. 2025 May;99(5):1865-1891. doi: 10.1007/s00204-025-04041-z. Epub 2025 Apr 11.
6
ACOT12, a novel factor in the pathogenesis of kidney fibrosis, modulates ACBD5.ACOT12是肾纤维化发病机制中的一个新因素,可调节ACBD5。
Exp Mol Med. 2025 Feb;57(2):478-488. doi: 10.1038/s12276-025-01406-3. Epub 2025 Feb 13.
7
Sirtuins in kidney homeostasis and disease: where are we now?肾脏稳态与疾病中的沉默调节蛋白:我们目前的进展如何?
Front Endocrinol (Lausanne). 2025 Jan 22;15:1524674. doi: 10.3389/fendo.2024.1524674. eCollection 2024.
8
Modulation of the thiol redox proteome by sugarcane ash-derived silica nanoparticles: insights into chronic kidney disease of unknown etiology.甘蔗灰衍生的二氧化硅纳米颗粒对硫醇氧化还原蛋白质组的调节作用:对病因不明的慢性肾脏病的见解
Part Fibre Toxicol. 2025 Feb 6;22(1):3. doi: 10.1186/s12989-025-00619-8.
9
The role of inflammatory response and metabolic reprogramming in sepsis-associated acute kidney injury: mechanistic insights and therapeutic potential.炎症反应和代谢重编程在脓毒症相关急性肾损伤中的作用:机制见解和治疗潜力。
Front Immunol. 2024 Oct 31;15:1487576. doi: 10.3389/fimmu.2024.1487576. eCollection 2024.
10
Exploring the role and therapeutic potential of lipid metabolism in acute kidney injury.探讨脂质代谢在急性肾损伤中的作用和治疗潜力。
Ren Fail. 2024 Dec;46(2):2403652. doi: 10.1080/0886022X.2024.2403652. Epub 2024 Sep 25.
黄连素通过促进糖尿病肾病肾小管上皮细胞的脂肪酸氧化来减少脂质积累。
Front Pharmacol. 2022 Jan 5;12:729384. doi: 10.3389/fphar.2021.729384. eCollection 2021.
4
STAT6 contributes to renal fibrosis by modulating PPARα-mediated tubular fatty acid oxidation.STAT6 通过调节 PPARα 介导的管状脂肪酸氧化促进肾纤维化。
Cell Death Dis. 2022 Jan 19;13(1):66. doi: 10.1038/s41419-022-04515-3.
5
Exosomes isolated from melatonin-stimulated mesenchymal stem cells improve kidney function by regulating inflammation and fibrosis in a chronic kidney disease mouse model.从褪黑素刺激的间充质干细胞中分离出的外泌体,通过调节慢性肾病小鼠模型中的炎症和纤维化来改善肾功能。
J Tissue Eng. 2021 Nov 29;12:20417314211059624. doi: 10.1177/20417314211059624. eCollection 2021 Jan-Dec.
6
Bone Marrow-Derived Mesenchymal Stem Cells Ameliorate Sepsis-Induced Acute Kidney Injury by Promoting Mitophagy of Renal Tubular Epithelial Cells the SIRT1/Parkin Axis.骨髓间充质干细胞通过 SIRT1/Parkin 轴促进肾小管上皮细胞的线粒体自噬来改善脓毒症诱导的急性肾损伤。
Front Endocrinol (Lausanne). 2021 Jun 25;12:639165. doi: 10.3389/fendo.2021.639165. eCollection 2021.
7
The tissue origin of human mesenchymal stem cells dictates their therapeutic efficacy on glucose and lipid metabolic disorders in type II diabetic mice.人骨髓间充质干细胞的组织来源决定了其在 II 型糖尿病小鼠糖脂代谢紊乱中的治疗效果。
Stem Cell Res Ther. 2021 Jul 7;12(1):385. doi: 10.1186/s13287-021-02463-x.
8
Human amniotic mesenchymal stem cells-conditioned medium protects mice from high-fat diet-induced obesity.人羊膜间充质干细胞条件培养基可保护小鼠免受高脂饮食诱导的肥胖。
Stem Cell Res Ther. 2021 Jun 26;12(1):364. doi: 10.1186/s13287-021-02437-z.
9
Mesenchymal Stem Cell-Derived Extracellular Vesicles: A Potential Therapeutic Strategy for Acute Kidney Injury.间质干细胞衍生的细胞外囊泡:急性肾损伤的一种潜在治疗策略。
Front Immunol. 2021 Jun 3;12:684496. doi: 10.3389/fimmu.2021.684496. eCollection 2021.
10
PPAR control of metabolism and cardiovascular functions.过氧化物酶体增殖物激活受体(PPAR)对代谢和心血管功能的调控。
Nat Rev Cardiol. 2021 Dec;18(12):809-823. doi: 10.1038/s41569-021-00569-6. Epub 2021 Jun 14.